Xeroderma (dry skin disease of the eyes) - Symptoms, Causes, Treatment & Prevention

Overview

Xeroderma, also called ocular surface xerosis or “dry‑skin disease of the eyes,” is a condition in which the skin and the mucous membranes covering the eyelids and conjunctiva become abnormally dry, flaky, and sometimes cracked. Although “xeroderma” is more commonly known as a genetic predisposition to skin cancer (xeroderma pigmentosum), in ophthalmology the term describes a chronic, non‑infectious dryness that affects the eyelid margin, the ocular surface, and the skin of the peri‑ocular region.

• Who it affects: Adults over 40 years are most commonly affected, but it can occur at any age, including in children with severe atopic dermatitis or autoimmune disease.
• Prevalence: Population‑based studies estimate that 5–10 % of adults in the United States have clinically significant ocular surface dryness (often overlapping with dry‑eye disease). Approximately 1–2 % develop associated skin xerosis of the eyelids that requires treatment.¹

The condition is usually chronic, slowly progressive, and may be associated with other ocular surface disorders such as meibomian gland dysfunction, allergic conjunctivitis, or systemic diseases like Sjögren’s syndrome.

Symptoms

Symptoms can range from mild irritation to severe discomfort. Common features include:

• Itching or burning sensation on the eyelids or around the eyes.
• Stinging or foreign‑body sensation – the feeling that something is in the eye.
• Redness (hyperemia) of the eyelid margin and conjunctiva.
• Flaking or scaling of the skin on the eyelids, often resembling eczema.
• Crusting or matting of eyelashes, especially after sleep.
• Dry, gritty texture on the ocular surface, leading to blurry vision that improves with blinking.
• Photophobia (light sensitivity) due to exposed, unlubricated corneal surface.
• Excessive tearing (reflex tearing) as the eye tries to compensate for dryness.
• Eye fatigue after reading or screen use.
• Skin tightness or “tight‑rope” feeling around the brow line.
• Secondary infection signs (pus, worsening redness) – these indicate complications and require urgent care.

Causes and Risk Factors

Xeroderma of the eyes is typically multifactorial. Understanding the underlying mechanisms helps tailor treatment.

Primary Causes

1. Meibomian Gland Dysfunction (MGD) – impaired oil secretion leads to a thin tear film that evaporates quickly.
2. Epidermal Barrier Disruption – loss of lipids and natural moisturizing factors in the eyelid skin, often due to atopic dermatitis or contact dermatitis.
3. Reduced Lacrimal Secretions – age‑related decline or autoimmune destruction of tear‑producing glands.
4. Environmental Stressors – low humidity, wind, air‑conditioning, UV exposure.
5. Medication Effects – antihistamines, isotretinoin, beta‑blockers, and certain antidepressants decrease tear production.
6. Systemic Autoimmune Diseases – Sjögren’s syndrome, rheumatoid arthritis, and lupus can cause both ocular dryness and skin xerosis.

Risk Factors

• Age > 40 years
• Female sex (hormonal influences on tear film)
• History of atopic dermatitis, eczema, or rosacea
• Prolonged screen time or visual tasks that reduce blink rate
• Contact lens wear, especially with improper hygiene
• Living in dry climates or high‑altitude regions
• Occupations with exposure to irritants (e.g., spray painters, hairdressers)
• Use of ocular cosmetics containing fragrances or preservatives

Diagnosis

Accurate diagnosis requires a combination of patient history, clinical examination, and specialized tests.

Clinical History

• Duration and pattern of symptoms
• Medication and systemic disease review
• Environmental and occupational exposures
• Use of cosmetics, contact lenses, or eye drops

Physical Examination

• Slit‑lamp biomicroscopy – evaluates eyelid margin, meibomian gland openings, conjunctival redness, and corneal integrity.
• Eyelid skin assessment – looks for scaling, fissuring, or eczema.
• Lid eversion – to examine the tarsal conjunctiva for dryness.

Diagnostic Tests

1. Schirmer Test – filter paper strip placed under the lower lid for 5 minutes; <10 mm indicates reduced tear production.
2. Tear Break‑up Time (TBUT) – fluorescein dye is applied; time < 10 seconds suggests unstable tear film.
3. Meibography – infrared imaging to visualize meibomian gland loss.
4. Ocular Surface Staining – fluorescein, lissamine green, or rose bengal highlight areas of epithelial damage.
5. Lipid Layer Thickness Measurement – using interferometry to quantify tear‑film lipids.
6. Skin Barrier Tests – transepidermal water loss (TEWL) measurements on the eyelid skin can confirm xerosis.

Treatment Options

Treatment is individualized, aiming to restore the ocular surface, repair the skin barrier, and address underlying causes.

Topical Medications

• Lipid‑containing artificial tears (e.g., Systane® Balance, Refresh® Optive) – 4–6 times daily.
• Preserved‑free lubricating ointments (e.g., Lacri‑Lube®, Refresh® PM) – applied at night for prolonged coverage.
• Corticosteroid eye drops (short‑term) – for significant inflammation; use under ophthalmologist supervision.
• Topical cyclosporine A 0.05 % (Restasis®) or lifitegrast 5 % (Xiidra®) – improve tear production in chronic cases.
• Eyelid skin moisturizers – ointments with ceramides, hyaluronic acid, or petrolatum; apply 2–3 times daily.
• Topical antibiotics (e.g., azithromycin eye drops) – useful when MGD is accompanied by bacterial overgrowth.

Procedural Interventions

• Thermal pulsed‑light (IPL) or intense pulsed light – reduces inflammation of meibomian glands.
• Meibomian gland expression (manual or device‑assisted) – clears clogged oil ducts.
• Lipid‑layer injections (e.g., autologous serum eye drops) – for severe deficiency.
• Punctal plugs – block tear drainage, increasing tear residence time.
• Botulinum toxin to the lacrimal gland – experimental, considered for refractory cases.

Lifestyle & Environmental Modifications

• Use a humidifier (≥ 40 % relative humidity) in work and bedroom environments.
• Avoid direct airflow from fans, AC vents, or heaters toward the face.
• Adopt the 20‑20‑20 rule: every 20 minutes, look 20 feet away for 20 seconds to restore blinking.
• Remove or replace eye cosmetics that contain fragrances or preservatives.
• Stay well‑hydrated (≈ 2 L water/day) and maintain a diet rich in omega‑3 fatty acids (fatty fish, flaxseed).²

Systemic Therapies (when indicated)

• Oral omega‑3 supplementation (1–2 g EPA/DHA daily).
• Short courses of oral tetracyclines (e.g., doxycycline 40 mg daily) for their anti‑inflammatory effect on meibomian glands.
• Management of underlying autoimmune disease (e.g., hydroxychloroquine for Sjögren’s).

Living with Xeroderma (dry skin disease of the eyes)

Long‑term self‑care can dramatically improve comfort and prevent flare‑ups.

• Daily eyelid hygiene – warm compresses for 5 minutes followed by gentle lid scrubs with diluted baby shampoo or commercially available eyelid cleansers.
• Moisturize the eyelid skin – apply a thin layer of non‑comedogenic ointment after cleaning, especially before bedtime.
• Protect eyes outdoors – wear wrap‑around sunglasses that block UV and wind.
• Schedule regular ophthalmology visits – at least once a year, or more often if symptoms change.
• Track triggers – keep a symptom diary noting diet, medication changes, screen time, and weather.
• Avoid smoking – tobacco smoke worsens ocular surface inflammation.

Prevention

While not all cases are preventable, risk can be reduced through proactive habits.

• Maintain adequate indoor humidity (30‑50 %).
• Limit exposure to irritants (smoke, harsh chemicals, wind).
• Use preservative‑free artificial tears before prolonged screen use.
• Implement proper contact lens hygiene or consider glasses if lenses aggravate dryness.
• Screen for systemic diseases (e.g., autoimmune disorders) early, especially in patients with persistent dry‑eye symptoms.
• Adopt a balanced diet rich in antioxidants (vitamins A, C, E) and omega‑3 fatty acids.

Complications

If left untreated, xeroderma of the eyes can lead to serious ocular and dermatologic problems.

• Corneal epithelial breakdown – leading to persistent ulcers and potential scarring.
• Infectious keratitis – bacterial, fungal, or viral infections due to compromised barrier.
• Conjunctival scarring (symblepharon) – adhesions that restrict eye movement.
• Chronic blepharitis – recurrent inflammation of the eyelid margin.
• Visual acuity loss from corneal opacities.
• Psychosocial impact – chronic discomfort can affect sleep, productivity, and quality of life.

When to Seek Emergency Care

---

Sources:

1. Mayo Clinic. “Dry eye.” Updated 2023. https://www.mayoclinic.org
2. National Eye Institute. “Omega‑3 Fatty Acids and Eye Health.” 2022. https://www.nei.nih.gov
3. Cleveland Clinic. “Blepharitis and Meibomian Gland Dysfunction.” 2024. https://my.clevelandclinic.org
4. American Academy of Ophthalmology. Preferred Practice Pattern: Dry Eye Disease. 2023.
5. World Health Organization. “Dry eye disease: an updated review.” 2021.